Mediclinic International Plc

Public consensus   -   Last updated 08/10/20

Reporting currency: GBP
Reporting unit: Absolute
 
NO. OF
FORECASTS
1H FY21
CONSENSUS
08/10/20
1H FY21
MIN
1H FY21
MAX
Hirslanden (CHF'm) - Adjusted
Revenue
7
829
816
845
EBITDA
7
101
85
121
EBITDA margin (%)
7
12.2
10.4
14.5
Average FX rate GBP/CHF
7
1.20
1.19
1.25
Southern Africa (ZAR'm) - Adjusted
Revenue
7
7,131
6,812
7,584
EBITDA
7
792
665
898
EBITDA margin (%)
7
11.1
9.8
13.0
Average FX rate GBP/ZAR
7
21.76
21.00
22.08
Middle East (AED'm) - Adjusted
Revenue
7
1,494
1,356
1,561
EBITDA
7
148
105
187
EBITDA margin (%)
7
9.9
7.3
12.0
Average FX rate GBP/AED
7
4.67
4.65
4.75
Adjusted Group (GBP'm)
Revenue
7
1,337
1,279
1,361
EBITDA
7
151
131
177
EBITDA margin (%)
7
11.3
10.2
13.2
Operating profit
n/a
n/a
n/a
n/a
Earnings per share (pence)
n/a
n/a
n/a
n/a
Dividend per share (pence)
n/a
n/a
n/a
n/a
Net Debt
n/a
n/a
n/a
n/a
Net cash generated from operating activities
n/a
n/a
n/a
n/a
Total Group Capex
n/a
n/a
n/a
n/a

Disclaimer

Mediclinic International plc (“Mediclinic”) does not endorse or adopt any of the consensus estimates expressed in this report. The report represents the views of analysts from which the consensus estimates are derived. Mediclinic will not provide any commentary on the consensus or answer questions on it. The circulation of the consensus by Mediclinic is not mandatory and Mediclinic may amend its practice on this at any time.